Life and Health Insurance

Aegon Ltd.

Aegon Ltd. released FY2025 Q3 earnings on February 19, 2026 (EST), with actual revenue of USD 3.249 B and EPS of USD 0.1365

Aegon Ltd. released FY2025 9 Months earnings on February 19, 2026 (EST), with actual revenue of USD 10.74 B and actual EPS of USD 0.5389

Aegon Ltd. released FY2025 annual earnings on February 19 Pre-Market (EST), actual revenue USD 14.05 B (forecast USD 11.65 B), actual EPS USD 0.6817

Aegon Ltd. released FY2025 Q4 earnings on February 19 Pre-Market (EST), actual revenue USD 3.253 B, actual EPS USD 0.1367

Aegon Ltd. to Release FY2025 Earnings Report on February 19, 2026 Pre-Market EST, Forecast Revenue USD 11.73 B

Dutch Global Insurance Group Plans to Relocate Headquarters to the US and Rebrand

Aegon Evaluating Options to Shed Non-US Businesses

Aegon Ltd. to Release FY2025 Q3 Earnings on November 22, 2025 (EST)

US Bank Securities analyst reiterates buy rating on Aegon NV stock

Gaspari Reiterates Hold Rating on Aegon NV

Aegon Ltd. released FY2025 Q2 earnings on August 21, 2025, EST with actual revenue of USD 3.894 B and EPS of USD 0.209

Aegon Ltd. released FY2025 Q1 earnings on August 21 (EST), actual revenue USD 3.601 B, actual EPS USD 0.1933

Aegon Ltd. released FY2025 Semi-Annual earnings on August 21 (EST), actual revenue USD 7.495 B, actual EPS USD 0.4024

Aegon Ltd. FY2025 Q2 Earnings Release on August 21, 2025 (EST)

Aegon Annual General Meeting Approves Dividends and Board Changes

Aegon Ltd. to Release FY2025 Q1 Earnings Report on May 22, Pre-Market EST

Marshall Wace LLP Increased Holdings in AEGON

Dutch Global Insurance Group Trading Volume and Stock Price Significantly Rise, Analyst Rating Upgraded to Buy

Aegon Ltd. released FY2024 9 Months Earnings on March 27 (EST), actual revenue 10.5 B USD, actual EPS 0.1854 USD

Aegon Ltd. released FY2024 Q3 earnings on March 27 (EST), actual revenue USD 3.585 B, actual EPS USD 0.2439

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

AEGOF

AEFC

Aegon has published the agenda for its Annual General Meeting (AGM) scheduled for June 10, 2026. The meeting will present the 2025 Annual Accounts and propose a final dividend of EUR 0.21 per common share, totaling EUR 0.40 for 2025. Proposals include extending Lard Friese's term as CEO until 2030 and appointing Leni Boeren to the Board. Corien Wortmann is not eligible for re-election, and Karen Fawcett will not stand for re-election. Shareholders can participate virtually and vote in advance. More details are available on Aegon's AGM webpage.

Fidelity

Aegon Funding Corp II Pref Share AEFC 5.1 12/15/49

Aegon NV

Aegon publishes agenda for 2026 Annual General Meeting

Aegon Ltd. has initiated a cash tender offer for five series of subordinated notes, including euro, U.S. dollar, and Dutch guilder-denominated securities. The offer, which runs until May 7, 2026, aims to manage Aegon's liability structure and financial leverage, providing investors an exit from legacy instruments. The purchase prices range from 75% to 89.625% of principal. Spark's analysis rates AEG stock as Neutral, citing attractive valuation but moderated by volatile financial performance. Aegon is a major player in global financial services, focusing on investment and retirement solutions.

Tip Ranks

Aegon Launches Tender Offer to Buy Back Five Series of Subordinated Notes

Aegon has proposed the sale of its U.K. insurance and pensions arm to Standard Life for GBP 750 million in cash and a 15.3% equity stake. The deal, expected to close by the end of 2026 pending regulatory approvals, will classify Aegon UK as held for sale and report results as discontinued operations from H1 2026. Aegon filed pro forma accounts illustrating the potential financial impact of the sale. Spark's analysis rates AEG stock as Neutral, citing attractive valuation but moderated by volatile performance.

Aegon Files Pro Forma Accounts for Proposed Sale of U.K. Insurance and Pensions Arm to Standard Life

In a report released on April 24, from Berenberg Bank maintained a Buy rating on Aegon NV, with a price target of €8.07. The company’s shares closed last Friday at €6.87.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on Aegon NV is a Moderate Buy with an average price target of €7.53.

Berenberg Bank Keeps Their Buy Rating on Aegon NV (0Q0Y)

PHNX

Standard Life's CEO Andy Briggs has expressed concerns about retirement adequacy while announcing a £2bn acquisition of Aegon UK, which will create the second largest retail pensions platform in the UK. The deal aims to enhance retirement standards for consumers and expand Standard Life's customer base. Briggs indicated potential for further mergers and acquisitions, emphasizing the importance of investing in customer outcomes amidst a competitive market. The acquisition is expected to boost annual profits by £160m and generate £400m in excess cash.

cityam

Phoenix Group Holdings plc

Standard Life’s Briggs warns ‘retirement adequacy is a genuine concern’, as £2bn Aegon deal unveiled

Standard Life has acquired Aegon UK for £2bn, creating the UK's largest retirement savings and income business with nearly 16 million customers and £480bn in assets. The deal is expected to boost annual profits by £160m and generate £400m in excess cash over five years. Funded through cash, debt, and shares, Aegon will become a strategic shareholder. CEO Andy Briggs stated the acquisition strengthens their financial position and accelerates a shift to a capital-light model.

Standard Life snaps up Aegon UK for £2bn to create savings giant